Common use of General Disagreements Clause in Contracts

General Disagreements. All disagreements within the Program Management Team and the Steering Committee shall be subject to the following: (a) The representatives to the Program Management Team or Steering Committee will negotiate in good faith for a period of not less than thirty (30) days to attempt to resolve the dispute. In the case of the Program Management Team, any unresolved dispute shall be referred to the Steering Committee for good faith negotiations for an additional period of not less than thirty (30) days to attempt to resolve the dispute. (b) In the event that the dispute is not resolved after the period specified in clause (a), the representatives shall promptly present the disagreement to the Chief Executive Officers of Dyax and Genzyme or a designee of such Chief Executive Officer reasonably acceptable to the other Party. (c) Such executives shall meet or discuss in a telephone or video conference each of Dyax and Genzyme's views and explain the basis for such dispute. (d) If such executives cannot resolve such disagreement within sixty (60) days after such issue has been referred to them, then such dispute shall be referred to arbitration as described in Section 14.10 hereof.

Appears in 4 contracts

Samples: Collaboration Agreement (Genzyme Corp), Collaboration Agreement (Dyax Corp), Collaboration Agreement (Dyax Corp)

AutoNDA by SimpleDocs

General Disagreements. All disagreements within the Program Management --------------------- Team and or the Steering Committee shall be subject to the following: (a) The representatives to the Program Management Team or Steering Committee (as the case may be) will negotiate in good faith for a period of not less than thirty (30) days to attempt to resolve the dispute. In the case of the Program Management Team, any unresolved dispute shall be referred to the Steering Committee for good faith negotiations for an additional period of not less than thirty (30) days to attempt to resolve the dispute. (b) In the event that the dispute is not resolved after the period specified in clause (a), the representatives shall promptly present the disagreement to the Chief Executive Officers of Dyax BioMarin and Genzyme or a designee of such Chief Executive Officer reasonably acceptable to the other Party. (c) Such executives shall meet or discuss in a telephone or video conference each of Dyax BioMarin and Genzyme's views and explain the basis for such dispute. (d) If such executives cannot resolve such disagreement within sixty thirty (6030) days after such issue has been referred to them, then such dispute shall be referred to arbitration as described in Section 14.10 hereof.

Appears in 2 contracts

Samples: Collaboration Agreement (Biomarin Pharmaceutical Inc), Collaboration Agreement (Biomarin Pharmaceutical Inc)

General Disagreements. All disagreements within the Program Management Team and the Steering Committee shall be subject to the following: (a) The representatives to the Program Management Team or Steering Committee will negotiate in good faith for a period of not less than thirty (30) days to attempt to resolve the dispute. In the case of the Program Management Team, any unresolved dispute shall be referred to the Steering Committee for good faith negotiations for an additional period of not less than thirty (30) days to attempt to resolve the dispute. (b) In the event that the dispute is not resolved after the period specified in clause (a)) above, the representatives shall promptly present the disagreement to the Chief Executive Officers Officer of Dyax each of GelTex and Genzyme or a designee of such Chief Executive Officer reasonably acceptable to the other Party. (c) Such executives shall meet or discuss in a telephone or video conference each of Dyax GelTex and Genzyme's views and explain the basis for such dispute. (d) If such executives cannot resolve such disagreement within sixty (60) days after such issue has been referred to them, then such dispute shall be referred to arbitration as described in Section 14.10 hereof.

Appears in 2 contracts

Samples: Collaboration Agreement (Geltex Pharmaceuticals Inc), Collaboration Agreement (Geltex Pharmaceuticals Inc)

General Disagreements. All disagreements within the Program Management Team and the Steering Committee shall be subject to the following: (a) The representatives to the Program Management Team or Steering Committee will negotiate in good faith for a period of not less than thirty (30) days to attempt to resolve the dispute. In the case of the Program Management Team, any unresolved dispute shall be referred to the Steering Committee for good faith negotiations for an additional period of not less than thirty (30) days to attempt to resolve the dispute. (b) In the event that the dispute is not resolved after the period specified in clause (a), the representatives shall promptly present the disagreement to the Chief Executive Officers of Dyax GTC and Genzyme or a designee of such Chief Executive Officer reasonably acceptable to the other Party. (c) Such executives shall meet or discuss in a telephone or video conference each of Dyax GTC and Genzyme's views and explain the basis for such dispute. (d) If such executives cannot resolve such disagreement within sixty (60) days after such issue has been referred to them, then such dispute shall be referred to arbitration as described in Section 14.10 14.11 hereof.

Appears in 2 contracts

Samples: Collaboration Agreement (GTC Biotherapeutics Inc), Collaboration Agreement (Genzyme Transgenics Corp)

AutoNDA by SimpleDocs

General Disagreements. All disagreements within the Program Management Team and the Steering Committee shall be subject to the following: (a) The representatives to the Program Management Team or Steering Committee will negotiate in good faith for a period of not less than thirty (30) days to attempt to resolve the dispute. In the case of the Program Management Team, any unresolved dispute shall be referred to the Steering Committee for good faith negotiations for an additional period of not less than thirty (30) days to attempt to resolve the dispute. (b) In the event that the dispute is not resolved after the period specified in clause (a), the representatives shall promptly present the disagreement to the Chief Executive Officers Officer of Dyax each of Diacrin and Genzyme or a designee of such Chief Executive Officer reasonably acceptable to the other Party. (c) Such executives shall meet or discuss in a telephone or video conference each of Dyax Diacrin and Genzyme's views and explain the basis for such dispute. (d) If such executives cannot resolve such disagreement within sixty (60) days after such issue has been referred to them, then such dispute shall be referred to arbitration as described in Section 14.10 hereof.14.10..

Appears in 2 contracts

Samples: Collaboration Agreement (Diacrin Inc /De/), Collaboration Agreement (Diacrin Inc /De/)

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!